Enhanced Care Coordination for Head and Neck Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 8, 2020

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Head and Neck Cancer
Interventions
BEHAVIORAL

Symptom Assessment

"Examine the symptomatology of head and neck cancer patients undergoing treatment that includes radiation by completing the M.D. Anderson Symptom Inventory for Head and Neck Cancer (MDASI-HN), the Brief Pain Index (BPI)and the Functional Assessment of Cancer Therapy for Head and Neck Cancer (FACT-H\&N). They will also be asked to complete the Hearing Handicap Inventory for Adults - Screening (HHIA-S) and the Tinnitus Handicap Inventory - Screening (THI-S) as well as the Flourishing Measure.~Each patient enrolled will be followed by a nurse and speech-language pathologist, twice a week, throughout their treatment (from start until 3-month post completion) All assessments are collected on a secure Ipad through REDcap database. If any significant changes occur, within 2 points from their last assessment, the nurse will notify the oncology physician and provide plan of care to avoid emergency room or hospital visit."

Trial Locations (1)

15213

Eye and Ear Institute, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT04813172 - Enhanced Care Coordination for Head and Neck Cancer Survivors | Biotech Hunter | Biotech Hunter